Research
74 papers- Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.Circulation · 2022
- Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations.Oncogene · 2022
- [Effect and molecular mechanism of hesperadin-induced ferroptosis in chronic myeloid leukemia K562 cells].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024
- Human Aurora kinase inhibitor Hesperadin reveals epistatic interaction between Plasmodium falciparum PfArk1 and PfNek1 kinases.Communications biology · 2020
- MST4 Kinase Inhibitor Hesperadin Attenuates Autophagy and Behavioral Disorder via the MST4/AKT Pathway in Intracerebral Hemorrhage Mice.Behavioural neurology · 2020
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443873334 | ImageFile = hesperadin.svg | ImageClass = skin-invert-image | ImageSize=200px | PIN=N-[(3Z)-2-Oxo-3-(phenyl{4-[(piperidin-1-yl)methyl]anilino}methylidene)-2,3-dihydro-1H-indol-5-yl]ethanesulfonamide | OtherNames= |Section1= |Section2= |Section3= }}
Hesperadin is an aurora kinase inhibitor.
Excerpted from Wikipedia’s “hesperadin” article, available under the CC BY-SA 4.0 licence.